Tags

Type your tag names separated by a space and hit enter

Short-incubation mass spectrometry assay for lysosomal storage disorders in newborn and high-risk population screening.

Abstract

The interest in early detection strategies for lysosomal storage disorders (LSDs) in newborns and high-risk population has increased in the last years due to the availability of novel treatment strategies coupled with the development of diagnostic techniques. We report the development of a short-incubation mass spectrometry-based protocol that allows the detection of Gaucher, Niemann-Pick A/B, Pompe, Fabry and mucopolysaccharidosis type I disease within 4h including sample preparation from dried blood spots. Optimized sample handling without the need of time-consuming offline preparations, such as liquid-liquid and solid-phase extraction, allows the simultaneous quantification of five lysosomal enzyme activities using a cassette of substrates and deuterated internal standards. Applying incubation times of 3h revealed in intra-day CV% values ranging from 4% to 11% for all five enzyme activities, respectively. In a first clinical evaluation, we tested 825 unaffected newborns and 16 patients with LSDs using a multiplexed, turbulent flow chromatography-ultra high performance liquid chromatography-tandem mass spectrometer assay. All affected patients were identified accurately and could be differentiated from non-affected newborns. In comparison to previously published two-day assays, which included an overnight incubation, this protocol enabled the detection of lysosomal enzyme activities from sample to first result within half a day.

Authors+Show Affiliations

Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, Austria.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

23122395

Citation

Mechtler, Thomas P., et al. "Short-incubation Mass Spectrometry Assay for Lysosomal Storage Disorders in Newborn and High-risk Population Screening." Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, vol. 908, 2012, pp. 9-17.
Mechtler TP, Metz TF, Müller HG, et al. Short-incubation mass spectrometry assay for lysosomal storage disorders in newborn and high-risk population screening. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;908:9-17.
Mechtler, T. P., Metz, T. F., Müller, H. G., Ostermann, K., Ratschmann, R., De Jesus, V. R., Shushan, B., Di Bussolo, J. M., Herman, J. L., Herkner, K. R., & Kasper, D. C. (2012). Short-incubation mass spectrometry assay for lysosomal storage disorders in newborn and high-risk population screening. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 908, 9-17. https://doi.org/10.1016/j.jchromb.2012.09.012
Mechtler TP, et al. Short-incubation Mass Spectrometry Assay for Lysosomal Storage Disorders in Newborn and High-risk Population Screening. J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Nov 1;908:9-17. PubMed PMID: 23122395.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Short-incubation mass spectrometry assay for lysosomal storage disorders in newborn and high-risk population screening. AU - Mechtler,Thomas P, AU - Metz,Thomas F, AU - Müller,Hannes G, AU - Ostermann,Katharina, AU - Ratschmann,Rene, AU - De Jesus,Victor R, AU - Shushan,Bori, AU - Di Bussolo,Joseph M, AU - Herman,Joseph L, AU - Herkner,Kurt R, AU - Kasper,David C, Y1 - 2012/09/24/ PY - 2012/06/06/received PY - 2012/09/03/revised PY - 2012/09/06/accepted PY - 2012/11/6/entrez PY - 2012/11/6/pubmed PY - 2013/5/10/medline SP - 9 EP - 17 JF - Journal of chromatography. B, Analytical technologies in the biomedical and life sciences JO - J Chromatogr B Analyt Technol Biomed Life Sci VL - 908 N2 - The interest in early detection strategies for lysosomal storage disorders (LSDs) in newborns and high-risk population has increased in the last years due to the availability of novel treatment strategies coupled with the development of diagnostic techniques. We report the development of a short-incubation mass spectrometry-based protocol that allows the detection of Gaucher, Niemann-Pick A/B, Pompe, Fabry and mucopolysaccharidosis type I disease within 4h including sample preparation from dried blood spots. Optimized sample handling without the need of time-consuming offline preparations, such as liquid-liquid and solid-phase extraction, allows the simultaneous quantification of five lysosomal enzyme activities using a cassette of substrates and deuterated internal standards. Applying incubation times of 3h revealed in intra-day CV% values ranging from 4% to 11% for all five enzyme activities, respectively. In a first clinical evaluation, we tested 825 unaffected newborns and 16 patients with LSDs using a multiplexed, turbulent flow chromatography-ultra high performance liquid chromatography-tandem mass spectrometer assay. All affected patients were identified accurately and could be differentiated from non-affected newborns. In comparison to previously published two-day assays, which included an overnight incubation, this protocol enabled the detection of lysosomal enzyme activities from sample to first result within half a day. SN - 1873-376X UR - https://wwww.unboundmedicine.com/medline/citation/23122395/Short_incubation_mass_spectrometry_assay_for_lysosomal_storage_disorders_in_newborn_and_high_risk_population_screening_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1570-0232(12)00532-6 DB - PRIME DP - Unbound Medicine ER -